Has Parenteral Drugs (India) Ltd. been shortlisted under Additional Surveillance Measure (ASM)?

No, Parenteral Drugs (India) Ltd. has not been shortlisted under Additional Surveillance Measure (ASM).

Has Parenteral Drugs (India) Ltd. been shortlisted under Graded Surveillance Measure (GSM)?

No, Parenteral Drugs (India) Ltd. has not been shortlisted under Graded Surveillance Measure (GSM).

When did Parenteral Drugs (India) Ltd. exit Graded Surveillance Measure (GSM)?

Parenteral Drugs (India) Ltd. exited Graded Surveillance Measure (GSM) on 11 Dec, 2023.

What is Graded Surveillance Measure (GSM)?

Graded Surveillance Measure (GSM) is one of many surveillance measures implemented, by SEBI and Exchanges, on securities with price not commensurate with financial health and fundamentals like Earnings, Book value, Fixed assets, Net-worth, P/E multiple, Market Capitalisation etc.

What are the main objectives of Graded Surveillance Measure (GSM)?

<ul><li>Alert and advice investors to be extra cautious while dealing in these securities.</li><li>Advise market participants to carry out necessary due diligence while dealing in these securities.</li></ul>

Where can more details on Graded Surveillance Measure (GSM) be found?

<ul><li><a rel="nofollow noreferrer noopener" onClick="event.stopPropagation();" href="https://www.bseindia.com/downloads1/FAQ_GSM.zip" alt="FAQ booklet on GSM by BSE">FAQ booklet on GSM by BSE</a></li><li><a rel="nofollow noreferrer noopener" onClick="event.stopPropagation();" href="https://www.bseindia.com/markets/equity/EQReports/graded_surveil_measure.aspx" alt="GSM page on BSE website">GSM page on BSE website</a></li></ul>

Should shortlisting under Graded Surveillance Measure (GSM) be construed as an adverse action against the concerned company/entity?

The shortlisting of securities under Graded Surveillance Measure (GSM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.

What are the criteria for shortlisting scrips under Graded Surveillance Measure (GSM) framework?

The detailed criteria for shortlisting & review of securities under GSM Framework is given below:<br><br><b>Criteria I:</b><br>The following criteria shall be made applicable for inclusion of securities under GSM Framework.<ol><li>Securities with latest available Net worth (Share Capital + Reserves & Surplus – debit balance in P&L) less than or equal to Rs. 10 crores;</li><div class="row w35P cen fw600"><p class="col-xs-12 m0">AND</p></div><li>Securities with latest available Net Fixed Assets (Tangible Assets + Capital Work in Progress) less than or equal to Rs. 25 crores;</li><div class="row w35P cen fw600"><p class="col-xs-12 m0">AND</p></div><li>Securities with PE greater than 2 times PE of Benchmark Index (Nifty 500) OR negative PE.</li></ol><br><b>The following securities shall be excluded from the process of shortlisting of securities under GSM: </b><ol><li>Securities where the price discovery is yet to take place as per the provision of SEBI circulars CIR/MRD/DP/01/2012 and CIR/MRD/DP/02/2012 dated January 20, 2012.</li><li>Securities already under suspension;</li><li>Securities on which derivative products are available;</li><li>Securities as a part of any index (NSE or BSE);</li><li>Public Sector Enterprises and its subsidiaries, if available;</li><li>Securities listed during last 1 year through Initial Public Offering (IPO);</li><li>Securities which have paid a dividend for each of the last three preceding years;</li><li>Securities with Institutional holding greater than 10% only if the following conditions are met:</li><ul><li>If the promoter entity has not offloaded any share in the last 5 years;</li></ul><div class="row w35P cen fw600"><p class="col-xs-12 m0">AND</p></div><ul><li>The current trading price of the security is within the range of High & Low price in last 3 years of the respective security.</li></ul><li>Securities listed through Scheme of Arrangement involving Merger / Demerger during last 1 year:</li><ol><li>In case of demerger, the following condition shall be applicable:</li><ul><li>If the parent company is under purview of GSM, the resultant demerged companies shall also attract GSM.</li><li>If the parent company is not under purview of GSM, the resultant demerged companies shall not be part of GSM at the time of demerger and shall be considered during the subsequent quarterly review.</li></ul><li> In case of merger of companies, if any of the securities at time of merger are under the purview of GSM, then the same shall be continued on the resultant entity.</li></ol></ol><br><b>Criteria II:</b><br>The following criteria shall be made applicable for inclusion of securities.<ol><li>Securities with full market capitalization less than Rs. 25 crore;</li><div class="row w35P cen fw600"><p class="col-xs-12 m0">AND</p></div><li>Securities with PE greater than 2 times PE of Benchmark Index (Nifty 500); </li><div class="row w35P cen fw600"><p class="col-xs-12 m0">OR</p></div><li>Securities with negative PE, the following should be considered:</li><ul><li>P/B (Price to Book) value of scrip greater than 2 times the P/B value of Benchmark Index (Nifty 500)</li></ul><div class="row w35P cen fw600"><p class="col-xs-12 m0">OR</p></div><ul><li>P/B value is negative</li></ul></ol>

What is Additional Surveillance Measure (ASM)?

Additional Surveillance Measure (ASM) is part of SEBI and the Exchanges initiative to enhance market integrity and safeguard the interest of investors. The ASM list is a list of securities that are currently getting monitored due to factors like price fluctuation, volatility, volume variance, etc.

What are the main objectives of and Additional Surveillance Measure (ASM)?

<ul><li>Alert and advice investors to be extra cautious while dealing in these securities.</li><li>Advise market participants to carry out necessary due diligence while dealing in these securities.</li></ul>

Where can more details on Additional Surveillance Measure (ASM) be found?

<ul><li><a rel="nofollow noreferrer noopener" onClick="event.stopPropagation();" href="https://www.bseindia.com/downloads1/FAQ_ASM.zip" alt="FAQ booklet on ASM by BSE">FAQ booklet on ASM by BSE</a><li><a rel="nofollow noreferrer noopener" onClick="event.stopPropagation();" href="https://www.bseindia.com/markets/equity/EQReports/additional_surveillance_measure.aspx" alt="ASM page on BSE website">ASM page on BSE website</a></li></ul>

Should shortlisting under Additional Surveillance Measure (ASM) be construed as an adverse action against the concerned company/entity?

The shortlisting of securities under Additional Surveillance Measure (ASM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.

What are the criteria for shortlisting scrips under Additional Surveillance Measure (ASM) framework?

The shortlisting of securities for placing in Additional Surveillance Measure (ASM) framework is based on an objective criteria as jointly decided by SEBI and Exchanges covering the following market based dynamic parameters:<ul><li>High Low Variation</li><li>Client Concentration</li><li>Close to Close Price Variation</li><li>Volume Variation</li><li>Delivery Percentage</li><li>No. of Unique PANs</li><li>PE</li></ul>

Parenteral Drugs (India) Ltd. ASM and GSM history as of Sep 17, 2025

Parenteral Drugs (India) Ltd. Additional Surveillance Measure (ASM) and Graded Surveillance Measure (GSM) as of Sep 17, 2025

LATEST STATUS

Not active in ASM or GSM

View all ASM/GSM stocks

History

Exchange	Long/Short Term	Stage	Entry date	Exit date
BSE	GSM	Stage 0	09 Jun 2023	11 Dec 2023
BSE	GSM	Stage I	18 Apr 2023	09 Jun 2023
BSE	GSM	Stage 0	13 Apr 2023	18 Apr 2023
BSE	GSM	Stage I	14 Mar 2023	13 Apr 2023
BSE	GSM	Stage II	10 Feb 2023	14 Mar 2023
BSE	GSM	Stage III	12 Jan 2023	10 Feb 2023
BSE	GSM	Stage II	06 Jan 2023	12 Jan 2023
BSE	GSM	Stage III	13 Dec 2022	06 Jan 2023
BSE	GSM	Stage IV	01 Nov 2022	13 Dec 2022
BSE	GSM	Stage III	21 Oct 2022	01 Nov 2022
BSE	GSM	Stage II	13 Oct 2022	21 Oct 2022
BSE	GSM	Stage I	07 Oct 2022	13 Oct 2022
BSE	GSM	Stage II	13 Sep 2022	07 Oct 2022
BSE	GSM	Stage III	05 Aug 2022	13 Sep 2022
BSE	GSM	Stage IV	30 Jun 2022	05 Aug 2022
BSE	GSM	Stage III	29 Jun 2022	30 Jun 2022
BSE	GSM	Stage II	28 Jun 2022	29 Jun 2022
BSE	GSM	Stage I	10 Jun 2022	28 Jun 2022
BSE	GSM	Stage II	06 May 2022	10 Jun 2022
BSE	GSM	Stage III	08 Apr 2022	06 May 2022
BSE	GSM	Stage IV	22 Feb 2022	08 Apr 2022
BSE	GSM	Stage III	11 Feb 2022	22 Feb 2022
BSE	GSM	Stage IV	11 Jan 2022	11 Feb 2022
BSE	GSM	Stage III	07 Jan 2022	11 Jan 2022
BSE	GSM	Stage IV	16 Nov 2021	07 Jan 2022
BSE	GSM	Stage III	29 Oct 2021	16 Nov 2021
BSE	GSM	Stage II	28 Oct 2021	29 Oct 2021
BSE	GSM	Stage I	08 Oct 2021	28 Oct 2021
BSE	GSM	Stage II	14 Sep 2021	08 Oct 2021
BSE	GSM	Stage III	06 Aug 2021	14 Sep 2021

FAQ

Has Parenteral Drugs (India) Ltd. been shortlisted under Additional Surveillance Measure (ASM)?

No, Parenteral Drugs (India) Ltd. has not been shortlisted under Additional Surveillance Measure (ASM).
Has Parenteral Drugs (India) Ltd. been shortlisted under Graded Surveillance Measure (GSM)?

No, Parenteral Drugs (India) Ltd. has not been shortlisted under Graded Surveillance Measure (GSM).
When did Parenteral Drugs (India) Ltd. exit Graded Surveillance Measure (GSM)?

Parenteral Drugs (India) Ltd. exited Graded Surveillance Measure (GSM) on 11 Dec, 2023.
What is Graded Surveillance Measure (GSM)?

Graded Surveillance Measure (GSM) is one of many surveillance measures implemented, by SEBI and Exchanges, on securities with price not commensurate with financial health and fundamentals like Earnings, Book value, Fixed assets, Net-worth, P/E multiple, Market Capitalisation etc.
What are the main objectives of Graded Surveillance Measure (GSM)?
- Alert and advice investors to be extra cautious while dealing in these securities.
- Advise market participants to carry out necessary due diligence while dealing in these securities.
Where can more details on Graded Surveillance Measure (GSM) be found?
- FAQ booklet on GSM by BSE
- GSM page on BSE website
Should shortlisting under Graded Surveillance Measure (GSM) be construed as an adverse action against the concerned company/entity?

The shortlisting of securities under Graded Surveillance Measure (GSM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.
What are the criteria for shortlisting scrips under Graded Surveillance Measure (GSM) framework?
The detailed criteria for shortlisting & review of securities under GSM Framework is given below:

Criteria I:
The following criteria shall be made applicable for inclusion of securities under GSM Framework.
1. Securities with latest available Net worth (Share Capital + Reserves & Surplus – debit balance in P&L) less than or equal to Rs. 10 crores;
2. Securities with latest available Net Fixed Assets (Tangible Assets + Capital Work in Progress) less than or equal to Rs. 25 crores;
3. Securities with PE greater than 2 times PE of Benchmark Index (Nifty 500) OR negative PE.
The following securities shall be excluded from the process of shortlisting of securities under GSM:
1. Securities where the price discovery is yet to take place as per the provision of SEBI circulars CIR/MRD/DP/01/2012 and CIR/MRD/DP/02/2012 dated January 20, 2012.
2. Securities already under suspension;
3. Securities on which derivative products are available;
4. Securities as a part of any index (NSE or BSE);
5. Public Sector Enterprises and its subsidiaries, if available;
6. Securities listed during last 1 year through Initial Public Offering (IPO);
7. Securities which have paid a dividend for each of the last three preceding years;
8. Securities with Institutional holding greater than 10% only if the following conditions are met:
9. Securities listed through Scheme of Arrangement involving Merger / Demerger during last 1 year:
Criteria II:
The following criteria shall be made applicable for inclusion of securities.
1. Securities with full market capitalization less than Rs. 25 crore;
2. Securities with PE greater than 2 times PE of Benchmark Index (Nifty 500);
3. Securities with negative PE, the following should be considered:
What is Additional Surveillance Measure (ASM)?

Additional Surveillance Measure (ASM) is part of SEBI and the Exchanges initiative to enhance market integrity and safeguard the interest of investors. The ASM list is a list of securities that are currently getting monitored due to factors like price fluctuation, volatility, volume variance, etc.
What are the main objectives of and Additional Surveillance Measure (ASM)?
- Alert and advice investors to be extra cautious while dealing in these securities.
- Advise market participants to carry out necessary due diligence while dealing in these securities.
Where can more details on Additional Surveillance Measure (ASM) be found?
- FAQ booklet on ASM by BSE
- ASM page on BSE website
Should shortlisting under Additional Surveillance Measure (ASM) be construed as an adverse action against the concerned company/entity?

The shortlisting of securities under Additional Surveillance Measure (ASM) is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/entity.
What are the criteria for shortlisting scrips under Additional Surveillance Measure (ASM) framework?
The shortlisting of securities for placing in Additional Surveillance Measure (ASM) framework is based on an objective criteria as jointly decided by SEBI and Exchanges covering the following market based dynamic parameters:
- High Low Variation
- Client Concentration
- Close to Close Price Variation
- Volume Variation
- Delivery Percentage
- No. of Unique PANs
- PE